---
title: "Yorkville Advisors Pushes for Changes at OraSure Technologies with 6.4% Stake"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/299376331.md"
description: "Yorkville Advisors and Islet Management disclosed a 6.4% stake in OraSure Technologies via a Schedule 13D filing on Sep. 17, 2026. The group aims to enhance stockholder value by engaging with management on strategy and capital allocation, and may nominate directors for the 2027 annual meeting."
datetime: "2026-09-18T00:16:06.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/299376331.md)
  - [en](https://longbridge.com/en/news/299376331.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/299376331.md)
generator: "portal-rs"
---

# Yorkville Advisors Pushes for Changes at OraSure Technologies with 6.4% Stake

Yorkville Advisors, together with Islet Management, disclosed a 6.4% stake in OraSure Technologies, Inc. They filed a Schedule 13D on Sep. 17, 2026, after accumulating 4.41 million shares. The move signals plans to influence strategy and board composition, including potential director nominations.

**Investor Intent**

Yorkville Advisors and Islet formed a group on Sept. 11, 2026 to "work together to enhance stockholder value" at OraSure. They plan to engage with the board and management on strategy and capital allocation, and they are considering "the potential nomination of individuals to the Board" at the 2027 annual meeting.

The group agreed to coordinate SEC filings and communications and to pre-clear certain trades. They may buy more shares, sell shares, or talk with other shareholders and potential acquirers as they evaluate options to boost performance.

**Investor's Background**

Yorkville Advisors is an investment firm known for structured financing and event-driven strategies, often using PIPEs and convertible securities. Its affiliate, YA II PN, Ltd., directly holds 5.7% of OraSure’s shares, while Islet Management holds about 0.7%. Mark Angelo leads the Yorkville platform and oversees vehicles that invest in public equities and hybrid instruments.

Original SEC Filing: ORASURE TECHNOLOGIES INC \[ OSUR \] - SCHEDULE 13D - Sep. 17, 2026

**Disclaimer**

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.

### Related Stocks

- [OSUR.US](https://longbridge.com/en/quote/OSUR.US.md)

## Related News & Research

- [OraSure wins FDA EUA for OraQuick Ebola 2.0 rapid antigen test](https://longbridge.com/en/news/293383259.md)
- [Okta CEO Todd McKinnon disposes of USD 7.83 million in common shares](https://longbridge.com/en/news/300076807.md)
- [‘Far From Done,’ Says Top Investor About Sandisk Stock](https://longbridge.com/en/news/300141435.md)
- [Banca Popolare di Cortona buys 5% stake in Dometria](https://longbridge.com/en/news/300143901.md)
- [U.S. Investigation into CrowdStrike (CRWD) Ends with No Charges Being Filed](https://longbridge.com/en/news/300158337.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**